Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A morbid condition due to the presence of sulfmethemoglobin in the blood. It is marked by persistent cyanosis, but the blood count does not reveal any special abnormality in the blood. It is thought to be caused by the action of hydrogen sulfide absorbed from the intestine. (Stedman, 25th ed)
No clinical trials have been registered for sulfhemoglobinemia.
3 publications have been identified in PubMed for sulfhemoglobinemia. Research spans Case Report / Case Series (100%).
Degrève S (2025). [PMID: 40979008](https://pubmed.ncbi.nlm.nih.gov/40979008/). *Cureus*. [Case Report / Case Series]
Mansour MM (2025). [PMID: 40329513](https://pubmed.ncbi.nlm.nih.gov/40329513/). *The American journal of case reports*. [Case Report / Case Series]
Bai S (2024). [PMID: 39070456](https://pubmed.ncbi.nlm.nih.gov/39070456/). *Cureus*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Oct 4, 2026, 3:02 AM UTC